Coverage
-
March 04, 2016
A New Jersey federal judge has held that a licensing and supply agreement a small pharmaceutical company inked with an entity for the anti-nausea drug Aloxi did not trigger the “on-sale bar” under the America Invents Act.
1 other articles on this case.
View all »